Ignite Creation Date:
2024-05-06 @ 8:27 AM
Last Modification Date:
2024-10-26 @ 12:01 PM
Study NCT ID:
NCT02749383
Status:
COMPLETED
Last Update Posted:
2016-04-25
First Post:
2015-09-30
Brief Title:
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Seborrheic Dermatitis
Sponsor:
Amorepacific Corporation
Organization:
Amorepacific Corporation
Study Overview
Official Title:
A Randomized Double-blind Single Center Investigator-initiated Clinical Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Subjects With Mild to Moderate Seborrheic Dermatitis of the Face
Status:
COMPLETED
Status Verified Date:
2016-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a Phase II single center randomized double-blind placebo-controlled study in male and female subjects aged 19 years with mild to moderate seborrheic dermatitis of the face All subjects will receive BID topical applications of PAC-14028 cream or vehicle for up to 4 weeks
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None